Publications by authors named "Lars Ek"

Claim this Profile
C
Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN).
Emelie Gezelius, Pär-Ola Bendahl, Widet Gallo, Kelin Gonçalves de Oliveira, Lars Ek

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience.
Marija Karadzovska-Kotevska, Hans Brunnström, Jaroslaw Kosieradzki, Lars Ek, Christel Estberg

PLoS One· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP).
Hervé Dutau, David Breen, Antonio Bugalho, Levent Dalar, Johannes Daniels, Lars Ek, Zsolt Papai-Szekely

Respiration· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer.
Miklos Gulyas, Johanna Sofia Margareta Mattsson, Andrea Lindgren, Lars Ek, Kristina Lamberg Lundström

Acta Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM).
Samuel V Kemp, Dirk-Jan Slebos, Alan Kirk, Malgorzata Kornaszewska, Kris Carron, Lars Ek

Am J Respir Crit Care Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of lung cancer CT screening in the Nordic countries.
Jesper Holst Pedersen, Jens Benn Sørensen, Zaigham Saghir, Øystein Fløtten, Odd Terje Brustugun, Lars Ek, Antti Jekunen

Acta Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer.
Kajsa Ericson Lindquist, Anna Karlsson, Per Levéen, Hans Brunnström, Christel Reuterswärd, Lars Ek

Oncotarget· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-way endobronchial valve for bronchopleural fistula after necrotizing pneumonia.
Tomas Gudbjartsson, Solveig Helgadottir, Lars Ek

Asian Cardiovasc Thorac Ann· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Bronchopleural fistula treated with endobronchial vent placement. Successful treatment of feared lung complication].
Gerdt C Riise, Gunnar Hillerdal, Lars Ek

Lakartidningen· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment.
Felix J F Herth, Ralf Eberhardt, Daniela Gompelmann, Joachim H Ficker, Manfred Wagner, Lars Ek

Eur Respir J· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy.
Sverre Sörenson, Helena Fohlin, Andrea Lindgren, Magnus Lindskog, Bengt Bergman, Lars Ek

Eur J Cancer· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic yield and efficacy of endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal lymphadenopathy.
Björn Jernlås, Henrik Nyberger, Lars Ek, Ronny Öhman, Per Jönsson

Clin Respir J· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: a double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group.
Andrea Koch, Bengt Bergman, Erik Holmberg, Christer Sederholm, Lars Ek

Eur J Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial.
Andreas Hermes, Bengt Bergman, Roy Bremnes, Lars Ek, Sverre Fluge

J Clin Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of olfactory dysfunction: the skövde population-based study.
Annika Brämerson, Leif Johansson, Lars Ek, Steven Nordin, Mats Bende

Laryngoscope· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis